Physician profile
Ryan Taylor Kitterman
NPI 1174811442
$2,922.01
in general payments reported to CMS, 2019-2025
28 companies · $78.18 in 2025
The $78.18 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,444 · 2020: $141 · 2021: $14.31 · 2022: $165 · 2023: $864 · 2024: $216 · 2025: $78.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815 · Travel and Lodging: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.38 |
| Travel and Lodging | $342.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,630.34 | 2019-2023 | Portfolio |
| Smith+Nephew, INC. | $336.85 | 2019-2025 | Stravix Mesh, Grafix Pl, Oasis |
| Melinta Therapeutics, LLC | $115.74 | 2019-2020 | |
| Kci USA, INC. | $100.69 | 2019-2021 | |
| Stryker Corporation | $97.69 | 2020-2024 | N/A, Sonicpin |
| Medtronic, INC. | $86.97 | 2022 | |
| Organogenesis INC. | $86.58 | 2022-2025 | Puraply, Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $64.88 | 2022-2024 | Nuzyra |
| Treace Medical Concepts, INC. | $59.97 | 2022-2024 | |
| Mimedx Group, INC. | $35.25 | 2024 | |
| Polynovo North America LLC | $33.35 | 2022-2023 | |
| Nevro Corp. | $25.36 | 2023 | Senza |
| Aroa Biosurgery Incorporated | $24.49 | 2023 | |
| Abbott Laboratories | $21.75 | 2023 | Proclaim |
| Idorsia Pharmaceuticals US INC | $20.38 | 2024 | Quviviq |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $18.57 | 2024 | Fanapt |
| Kerecis Limited | $17.67 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $17.39 | 2019 | |
| Lilly USA, LLC | $17.15 | 2024 | Mounjaro |
| Osiris Therapeutics INC. | $16.46 | 2019 | |
| Arthrosurface Incorporated | $12.67 | 2019 | |
| Acell, INC. | $12.54 | 2020 | |
| Wright Medical Technology, INC. | $12.28 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.02 | 2022 | |
| Allergan, INC. | $11.96 | 2019 | |
| Integra Lifesciences Corporation | $11.08 | 2019 | |
| Merck Sharp & Dohme LLC | $11.01 | 2019 | |
| 3m Company | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kitterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.